Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine versus bupivacaine TAP block after open appendectomy
IRCT20211112053042N1Phase 3Completed
- Sponsor
- Alborz University of Medical Sciences
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in acute postoperative pain comparing Ropivacaine TAP block with Bupivacaine TAP block (2 arms). Primary endpoint: Pain. Started Dec 2021; status: completed.
02
Drugs
ropivacainebupivacaine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on IRCT20211112053042N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211112053042N1.